Trade Summary

3 days ago, Pham Quang X, serving as CEO and Chairman at Cadrenal Therapeutics, Inc. (CVKD), sold 8,285 shares at $4.37 per share, for a total transaction value of $36,209.04. Following this transaction, Pham Quang X now holds 173,224 shares of CVKD.

This sale represents a 4.56% decrease in Pham Quang X's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 5:26 PM ET, 2 days after the trade was made.

Cadrenal Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.